BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 6763406)

  • 1. Mutation signatures specific to DNA alkylating agents in yeast and cancers.
    Saini N; Sterling JF; Sakofsky CJ; Giacobone CK; Klimczak LJ; Burkholder AB; Malc EP; Mieczkowski PA; Gordenin DA
    Nucleic Acids Res; 2020 Apr; 48(7):3692-3707. PubMed ID: 32133535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Essential Oil from the Resurrection Plant
    Pavela R; Ferrati M; Spinozzi E; Maggi F; Petrelli R; Rakotosaona R; Ricciardi R; Benelli G
    Pharmaceuticals (Basel); 2022 Dec; 15(12):. PubMed ID: 36558962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analytical Method Development for 19 Alkyl Halides as Potential Genotoxic Impurities by Analytical Quality by Design.
    Lee K; Yoo W; Jeong JH
    Molecules; 2022 Jul; 27(14):. PubMed ID: 35889310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variability in the Responses of Hepatitis B Virus D-Subgenotypes to Antiviral Therapy: Designing Pan-D-Subgenotypic Reverse Transcriptase Inhibitors.
    Khatun M; Kumar K; Baidya A; Mondal RK; Baszczyňski O; Kalčic F; Banerjee S; Dhali GK; Das K; Chowdhury A; Janeba Z; Chakrabarti S; Datta S
    J Virol; 2022 Jan; 96(2):e0180021. PubMed ID: 34730399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scientific Opinion on Flavouring Group Evaluation 74, Revision 4 (FGE.74Rev4): Consideration of aliphatic sulphides and thiols evaluated by JECFA (53rd and 61st meeting) structurally related to aliphatic and alicyclic mono-, di-, tri- and polysulphides with or without additional oxygenated functional groups from chemical group 20 evaluated by EFSA in FGE.08Rev5.
    ; Silano V; Bolognesi C; Castle L; Chipman K; Cravedi JP; Engel KH; Fowler P; Franz R; Grob K; Gürtler R; Husøy T; Kärenlampi S; Milana MR; Pfaff K; Riviere G; Srinivasan J; Tavares Poças MF; Tlustos C; Wölfle D; Zorn H; Benigni R; Brimer L; Mulder G; Oskarsson A; Svendsen C; van Benthem J; Anastassiadou M; Saarma S; Mennes W
    EFSA J; 2018 Mar; 16(3):e05167. PubMed ID: 32625823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scientific Opinion on Flavouring Group Evaluation 7, Revision 5 (FGE.07Rev5): saturated and unsaturated aliphatic secondary alcohols, ketones and esters of secondary alcohols and saturated linear or branched-chain carboxylic acids from chemical group 5.
    ; Silano V; Bolognesi C; Castle L; Cravedi JP; Engel KH; Fowler P; Franz R; Grob K; Gürtler R; Husøy T; Kärenlampi S; Milana MR; Penninks A; Tavares Poças MF; Smith A; Tlustos C; Wölfle D; Zorn H; Zugravu CA; Beckman Sundh U; Brimer L; Mosesso P; Mulder G; Anastassiadou M; Mennes W
    EFSA J; 2017 Mar; 15(3):e04725. PubMed ID: 32625434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanistic understanding of molecular initiating events (MIEs) using NMR spectroscopy.
    Sanderson PN; Simpson W; Cubberley R; Aleksic M; Gutsell S; Russell PJ
    Toxicol Res (Camb); 2016 Jan; 5(1):34-44. PubMed ID: 30090324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of mutagenic/carcinogenic potential of environmental contaminants by ion-molecule reactions and tandem mass spectrometry.
    Freeman JA; Johnson JV; Hail ME; Yost RA; Kuehl DW
    J Am Soc Mass Spectrom; 1990 Feb; 1(1):110-5. PubMed ID: 24248619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection and quantitation of acrolein-derived 1,N2-propanodeoxyguanosine adducts in human lung by liquid chromatography-electrospray ionization-tandem mass spectrometry.
    Zhang S; Villalta PW; Wang M; Hecht SS
    Chem Res Toxicol; 2007 Apr; 20(4):565-71. PubMed ID: 17385896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomonitoring studies and susceptibility markers for acrolein congeners and allylic and benzyl compounds.
    Eder E; Hoffman C; Sporer S; Scheckenbach S
    Environ Health Perspect; 1993 Mar; 99():245-7. PubMed ID: 8319634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro mutagenicity of valepotriates.
    von der Hude W; Scheutwinkel-Reich M; Braun R; Dittmar W
    Arch Toxicol; 1985 Feb; 56(4):267-71. PubMed ID: 3994511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytomorphological changes in liver cells exposed to allyl and benzyl isothiocyanate and their cysteine and glutathione conjugates.
    Temmink JH; Bruggeman IM; van Bladeren PJ
    Arch Toxicol; 1986 Jul; 59(2):103-10. PubMed ID: 3753191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of biotransformation in the genotoxicity of allylic compounds.
    Eder E; Dornbusch K; Fischer G
    Arch Toxicol; 1987; 60(1-3):182-6. PubMed ID: 3619639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanisms of DNA damage initiated by alpha, beta-unsaturated carbonyl compounds as criteria for genotoxicity and mutagenicity.
    Eder E; Hoffman C; Bastian H; Deininger C; Scheckenbach S
    Environ Health Perspect; 1990 Aug; 88():99-106. PubMed ID: 2272339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mode of action and the assessment of chemical hazards in the presence of limited data: use of structure-activity relationships (SAR) under TSCA, Section 5.
    Auer CM; Nabholz JV; Baetcke KP
    Environ Health Perspect; 1990 Jul; 87():183-97. PubMed ID: 2269224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutagenic properties of allylic and alpha, beta-unsaturated compounds: consideration of alkylating mechanisms.
    Eder E; Henschler D; Neudecker T
    Xenobiotica; 1982 Dec; 12(12):831-48. PubMed ID: 6763406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity relationships of alpha, beta-unsaturated carbonylic compounds.
    Henschler D; Eder E
    IARC Sci Publ; 1986; (70):197-205. PubMed ID: 3539786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NTP Technical Report on the comparative toxicity studies of allyl acetate (CAS No. 591-87-7), allyl alcohol (CAS No. 107-18-6) and acrolein (CAS No. 107-02-8) administered by gavage to F344/N rats and B6C3F1 mice.
    Irwin RD
    Toxic Rep Ser; 2006 Jul; (48):1-73, A1-H10. PubMed ID: 17160105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutagenic and cell-transforming activities of triol-epoxides as compared to other chrysene metabolites.
    Glatt H; Seidel A; Bochnitschek W; Marquardt H; Marquardt H; Hodgson RM; Grover PL; Oesch F
    Cancer Res; 1986 Sep; 46(9):4556-65. PubMed ID: 3524815
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.